Long-term maintenance of response and improved liver health with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): data from the MARCH-ON study
2023; Elsevier BV; Volume: 78; Linguagem: Inglês
10.1016/s0168-8278(23)00615-3
ISSN1600-0641
AutoresAlexander Miethke, Adib Moukarzel, Gilda Porta, Joshue Covarrubias Esquer, Piotr Czubkowski, Felipe Ordonez, M. Candusso, Amal Aqul, Robert H. Squires, Étienne Sokal, Daniel D’Agostino, Ulrich Baumann, Lorenzo D’Antiga, Nagraj Kasi, Nolwenn Laborde, Çiğdem Arıkan, Chuan-Hao Lin, Susan Gilmour, Naveen Mittal, Fang Kuan Chiou, Simon Horslen, Wolf‐Dietrich Huber, Tiago Nunes, Anamaria Lascau, Lara Longpre, Douglas Mogul, Raúl Antonio Aguilar Vera, Pamela Vig, Vera Hupertz, Regino P. González‐Peralta, Udeme D. Ekong, Jane Hartley, Noémie Laverdure, Nadia Ovchinsky, Richard Thompson,
Tópico(s)Liver Diseases and Immunity
Referência(s)